CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.
Conference
"Antiretroviral Therapy in Naīve Patients" Dr. Sharon Walmsley (biography) English - 2003-12-19 - 11 minutes
(6 slides)
Summary : The QUAD and Time Studies tested various regimens in ARV naīve patients. The QUAD Study tested a 4 drug regimen against a 3 drug regimen: TZV+SQV/R vs CBV+SQV/R. The Time Study looked at (TZV/EFV 48 weeks) vs (TZV/EFV 24 weeks followed by TZV 24 weeks) vs TZV 48 weeks. New data from these studies will be discussed here, as well as data on the time to treatment change from PI to NNRTI or 3RT therapy, and treatment simplification with once daily TDF/DDI/EFV.
Copyright Š 2004 E-MedHosting.com Inc.
Learning objectives : The participant will learn about new data presented at the 9th EACS Meeting on the following topics:
- QUAD Study in ARV naīve patients testing TZVor CBV in combination with boosted SQV.
- Time Study in ARV naīve patients testing (TZV/EFV 48 weeks) vs (TZV/EFV 24 weeks followed by TZV 24 weeks) vs TZV 48 weeks.
- Time to treatment change from PI to NNRTI or 3RT therapy.
- Treatment simplification with once daily TDF/DDI/EFV.
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
